# Dan Knox

> Dan Knox is a seed investor at Science Exchange (San Francisco) backing Finance and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Science Exchange](https://shizune.co/investors/profile/science-exchange)
- Location: San Francisco, United States
- Total investments: 2
- Last investment: Mar 2019
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/djkn0x
- X (Twitter): http://twitter.com/djkn0x
- Facebook: http://www.facebook.com/djkn0x

Dan Knox is a seed investor at Science Exchange in San Francisco focused on Finance and Health Care. Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Finance | 1 | 50% |
| Health Care | 1 | 50% |
| Crowdfunding | 1 | 50% |
| Biotechnology | 1 | 50% |
| Financial Services | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Mexico | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Unima | Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking. | $1.9M | Seed | Mar 24, 2019 |  |
| Experiment | Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by | $1.2M |  | Jun 01, 2013 |  |

2 of 2 investments shown.

## Co-investors
- [Avalancha Ventures](https://shizune.co/investors/profile/avalancha-ventures) — VC Fund, 1 deal together
- [Dadneo](https://shizune.co/investors/profile/dadneos) — VC Fund, 1 deal together
- [Venturance Alternative Assets](https://shizune.co/investors/profile/fondo-alerce-venture-capital) — VC Fund, 1 deal together
- [Fondo Vulcano](https://shizune.co/investors/profile/fondo-vulcano) — VC Fund, 1 deal together
- [Genesis Capital Ventures](https://shizune.co/investors/profile/genesis-capital-venture) — VC Fund, 1 deal together
- [Investo](https://shizune.co/investors/profile/investomex) — VC Fund, 1 deal together

## About Science Exchange

VC Fund · Palo Alto, United States

Science Exchange is the world’s leading R&D Services Management company, empowering research organizations to accelerate science and drive more innovation success. The Science Exchange Marketplace improves R&D productivity by automating many collaborative tasks between buyers and providers, such as obtaining quotes, managing projects andprocessing payments, all with rigorous data security and regulatory compliance embedded throughout.

5 contacts available at Science Exchange.

| Name | Title | Profile |
| --- | --- | --- |
| Dan Knox | Co-Founder & COO | https://shizune.co/investors/profile/daniel-knox |
| Elizabeth Iorns | Co-Founder, President & CEO | https://shizune.co/investors/profile/elizabeth-iorns |
| Freddy Rangel | Senior Software Engineer | https://shizune.co/investors/profile/freddy-rangel |
| Natalie Foote | Senior Director, Project Management | https://shizune.co/investors/profile/natalie-foote |
| Nicole Perfito | VP, Commercial Operations | https://shizune.co/investors/profile/nicole-perfito |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund
- [DOMO.VC](https://shizune.co/investors/profile/domo-invest) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in LATAM](https://shizune.co/investors/biotechnology-angel-investors-latam)
- [Biotechnology Angel Investors in Mexico](https://shizune.co/investors/biotechnology-angel-investors-mexico)
- [Biotech Angel Investors in LATAM](https://shizune.co/investors/biotech-angel-investors-latam)
- [Biotech Investors in Mexico](https://shizune.co/investors/biotech-investors-mexico)

## FAQ

### What does Dan Knox invest in?

Dan Knox invests primarily in Finance, Health Care and Crowdfunding startups, most often at Seed and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Mexico. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dan Knox last invest?

The most recent investment recorded for Dan Knox closed in Mar 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co